Structural
A cortical-cancellous structural allograft for ACDF with the high quality and proven clinical success you depend on from the global leader in fusion and cellular therapies
.png)
ARTHROFLEX®
Exceptional Handling.
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
Hear from three surgeons on their experience with using ViviGen in their patients.
Dr. Joseph S. Park, University of Virginia
Dr. John Hall, Flagstaff Bone and Joint
ViviGen is the first cellular allograft to focus on recovering, processing, and protecting viable, lineage committed bone cells. It is comprised of viable, cryopreserved corticocancellous bone matrix and demineralized bone. These three components of ViviGen provide the properties necessary for bone repair that include osteoinductive signals, osteoconductive bone scaffolds, and osteogenic cells.
Dr. Jeffrey Marschall, University of Iowa Hospitals and Clinics
Dr. Jeffrey Marschall on his use of ViviGen in complex CMF procedures
The Allograft Surgical Techniques Lab provides a unique hands-on opportunity to learn surgical techniques and develop expertise utilizing aortic allografts for AVR and pulmonary valve allografts for the Ross Procedure from a team of world-class surgeons from one of the top-ranked cardiology and heart surgery programs in the U.S., the Cleveland Clinic.
